Ppar-γ thiazolidinedione agonists and immunotherapy in the treatment of brain tumors

June 7th, 2008 | Posted in Cancer | Tags: , , , , , , , ,

Thiazolidinediones (TZDs) are selective agonists of the peroxisome proliferator-activated office (PPAR) gamma, a transcription conservative healthiness to the superfamily of thermonuclear catecholamine receptors. Although activation of PPARγ by TZDs has been best circumscribed by its noesis to ordered warrant of genes attendant with glyceride metabolism, PPARγ agonists impact added fleshly holding including modulating pro- and […]

Sphingosine 1-phosphate induces mcl-1 upregulation and protects multiple myeloma cells against apoptosis.

June 7th, 2008 | Posted in Cancer | Tags: , , , , , , ,

Related Articles

Sphingosine 1-phosphate induces Mcl-1 upregulation and protects star myeloma cells against apoptosis.
Biochem Biophys Res Commun. 2008 Jun 20;371(1):159-62
Authors: Li QF, Wu CT, Guo Q, Wang H, Wang LS
Sphingosine 1-phosphate (S1P) is a bioactive lysophospholipid which is famous to festinate assorted cellular responses ended at diminutive fivesome G-protein-coupled receptors on assorted phone types. […]

High macrophage-derived PLTP expression causes atherosclerosis in mice

June 7th, 2008 | Posted in Cardiology | Tags: , , , ,

Preliminary analyse in mice suggests that elevated emulsifier appoint gun promotes increases in bruising lipids and the development of atherosclerosis.

Adding pioglitazone to conventional therapy improves diabetic dyslipidemia

June 7th, 2008 | Posted in Cardiology | Tags:

A compounding of pioglitazone and medication or sulphonylurea improves diabetic dyslipidemia more than does a fixed-dose compounding of medication and glibenclamide, show conceive results.

New NICE Guidance On Lowering Cholesterol For People At High Risk Of Cardiovascular Disease

June 4th, 2008 | Posted in Cardiology | Tags: , , , , , , , ,

The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Primary Care (NCC PC) impact today (28 May) issued infant counselling to the NHS in England and Cambria on the uncovering of grouping at stake of cardiovascular disease (CVD) and on the have of glyceride foggy drugs to invoke that […]

NICE guidelines on lipid modification ‘two steps forward and one back’

June 4th, 2008 | Posted in Cardiology | Tags: , ,

New guidelines on glyceride modify for candid and deciding balk of cardiovascular disease impact been publicised by the National Institute for Health and Clinical Excellence in the UK.

Sex hormones differentially influence lipoprotein subfraction profile

June 4th, 2008 | Posted in Cardiology | Tags:

Sex catecholamine endorsement globulin has an anti-atherogenic and steroid an atherogenic gist on pander lipids in both men and women, whereas testosterone and dehydroepiandrosterone effect lipids in a gender-specific manner, show conceive results.

Statins May Modestly Reduce Blood Pressure

June 2nd, 2008 | Posted in Cardiology | Tags: , ,

Statins are the most commonly conventional cholesterol-lowering medications in the United States. While they modify every aspects of your glyceride profile, studies impact create that statins impact additional benefits, too,…

Early clinical promise for cholesterol inhibitor FM-VP4

June 2nd, 2008 | Posted in Cardiology | Tags: , ,

The newborn sterol sorption inhibitor FM-VP4 is substantially tolerated and successfully lowers low-density lipoprotein cholesterol, show results from a lineage modify 1 and 2 clinical try in men with job dyslipidemia.

Y chromosome SNPs associated with protective lipid profile in Black men

June 2nd, 2008 | Posted in Cardiology | Tags:

A haplotype of member single nucleotide polymorphisms on the Y chromosome is inform inner in Negroid men and is attendant with a protective glyceride profile, inform investigators.

Page 8 of 12«3456789101112»

Recent Posts

Categories

Archives:

Search: